Center-Authored Papers

Filters: Author is Riddell, S R  [Clear All Filters]
A
Alyea EP, DeAngelo DJ, Moldrem J, Pagel JM, Przepiorka D, Sadelin M, Young JW, Giralt S, Bishop M, Riddell SR.  2010.  NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignan. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(8):1037-69. Abstract
Anderson LD, Cook DR, Yamamoto TN, Berger C, Maloney DG, Riddell SR.  2011.  Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma.. Cancer immunology, immunotherapy : CII. 60(7):985-97. Abstract
B
Balakrishnan A, Goodpaster T, Randolph-Habecker J, Hoffstrom BG, Jalikis FG, Koch LK, Berger C, Kosasih PL, Rajan A, Sommermeyer D et al..  2017.  Analysis of ROR1 protein expression in human cancer and normal tissues.. Clinical cancer research : an official journal of the American Association for Cancer Research. 23(12):3061-3071. Abstract
Berger C, Berger M, Hackman RC, Gough M, Elliott C, Jensen MC, Riddell SR.  2009.  Safety and immunologic effects of IL-15 administration in nonhuman primates.. Blood. 114(12):2417-26. Abstract
Berger C, Berger M, Anderson D, Riddell SR.  2011.  A non-human primate model for analysis of safety, persistence, and function of adoptively transferred T cells.. Journal of medical primatology. 40(2):88-103. Abstract
Berger C, Sommermeyer D, Hudecek M, Berger M, Balakrishnan A, Paszkiewicz PJ, Kosasih PL, Rader C, Riddell SR.  2015.  Safety of targeting ROR1 in primates with chimeric antigen receptor-modified T cells.. Cancer immunology research. 3(2):206-16. Abstract
Berger C, Jensen MC, Lansdorp PM, Gough M, Elliott C, Riddell SR.  2008.  Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates.. The Journal of clinical investigation. 118(1):294-305. Abstract
Berger C, Berger M, Beard BC, Kiem H-P, Gooley TA, Riddell SR.  2013.  Proliferation-linked apoptosis of adoptively transferred T cells after IL-15 administration in macaques.. PloS one. 8(2):e56268. Abstract
Berger C, Turtle CJ, Jensen MC, Riddell SR.  2009.  Adoptive transfer of virus-specific and tumor-specific T cell immunity.. Current opinion in immunology. 21(2):224-32. Abstract
Bishop MR, Alyea EP, Cairo MS, Falkenburg FJH, June CH, Kröger N, Little RF, Miller JS, Pavletic SZ, Porter D et al..  2010.  Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(5):563-4.
Bishop MR, Alyea EP, Cairo MS, Falkenburg FJH, June CH, Kröger N, Little RF, Miller JS, Pavletic SZ, Porter DL et al..  2011.  National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(4):443-54. Abstract
Blaeschke F, Thiel U, Kirschner A, Thiede M, Rubio RA, Schirmer D, Kirchner T, Richter GHS, Mall S, Klar R et al..  2016.  Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T Cells specifically inhibit Ewing sarcoma growth in vitro and in vivo.. Oncotarget. Abstract
Bleakley M, Heimfeld S, Loeb KR, Jones LA, Chaney C, Seropian S, Gooley TA, Sommermeyer F, Riddell SR, Shlomchik WD.  2015.  Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.. The Journal of clinical investigation. 125(7):2677-89. Abstract
Bleakley M, Riddell SR.  2011.  Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia.. Immunology and cell biology. 89(3):396-407. Abstract
Bleakley M, Heimfeld S, Jones LA, Turtle C, Riddell SR, Shlomchik W.  2014.  Engineering Human Peripheral Blood Stem Cell Grafts That Are Depleted of Naïve T Cells and Retain Functional Pathogen-Specific Memory T cells.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(5):705-16. Abstract
Bleakley M, Otterud BE, Richardt JL, Mollerup AD, Hudecek M, Nishida T, Chaney CN, Warren EH, Leppert MF, Riddell SR.  2010.  Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells.. Blood. 115(23):4923-33. Abstract
Bleakley M, Turtle CJ, Riddell SR.  2012.  Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation.. Expert review of hematology. 5(4):409-25. Abstract
Brown CE, Starr R, Martinez C, Aguilar B, D'Apuzzo M, Todorov I, Shih C-C, Badie B, Hudecek M, Riddell SR et al..  2009.  Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.. Cancer research. 69(23):8886-93. Abstract
Budde LE, Berger C, Lin Y, Wang J, Lin X, Frayo SE, Brouns SA, Spencer DM, Till BG, Jensen MC et al..  2013.  Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma.. PloS one. 8(12):e82742. Abstract
Busch DH, Fräßle SP, Sommermeyer D, Buchholz VR, Riddell SR.  2016.  Role of memory T cell subsets for adoptive immunotherapy.. Seminars in immunology. 28(1):28-34. Abstract
C
Chapuis AG, Casper C, Kuntz S, Zhu J, Tjernlund A, Diem K, Turtle CJ, Cigal ML, Velez R, Riddell SR et al..  2011.  HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivo.. Blood. 117(20):5391-402. Abstract
D
Dai Z, Turtle CJ, Booth GC, Riddell SR, Gooley TA, Stevens AM, Spies T, Groh V.  2009.  Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus.. The Journal of experimental medicine. 206(4):793-805. Abstract
E
Elmacken M, Awasthi A, Ayello J, van de Ven C, Luo W, Liao Y, Riddell S, Cairo M.  2015.  ROR1 expressing neuroblastoma (NB), medulloblastoma (MB), and ewing’s sarcoma (ES) can be effectively targeted with nk cells modified to express an anti ROR1 chimeric antigen receptor (CAR). Cytotherapy. 17(6):S48.
G
Gardner RA, Finney O, Annesley C, Brakke H, Summers C, Leger K, Bleakley M, Brown C, Mgebroff S, Spratt K et al..  2017.  Intent to treat leukemia remission by CD19CAR T cells of defined formulation and dose in children and young adults.. Blood. Abstract
Gardner R, Wu D, Cherian S, Fang M, Hanafi L-A, Finney O, Smithers H, Jensen MC, Riddell SR, Maloney DG et al..  2016.  Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy.. Blood. 127(20):2406-2410. Abstract